Culture Biosciences
Culture Biosciences is a Cell Engineering & Bio-tools company founded in 2016 and based in South San Francisco, United States. It has raised $107M in total funding, most recently a Series C in 2025.
Founded in 2016 by engineers Will Patrick and Matt Ball, Culture Biosciences operates cloud-connected bioreactors that biotech companies use to run fermentation and cell-culture experiments remotely, with its Console software letting them design, monitor, and analyze runs from anywhere. The company offers its Stratyx 250 cloud-integrated bioreactor and a managed bioprocess-development service, helping customers developing therapeutics, materials, and foods iterate on manufacturing faster. Culture closed a Series C round in December 2025 led by existing investors including Northpond Ventures, Synthesis Capital, S32, and Cultivian Sandbox, for roughly $107M raised across six rounds.
Turns bioprocess development into a remote, software-driven service, compressing one of the slowest steps in scaling engineered biology.
culturebiosciences.com ↗·Cell Engineering & Bio-tools·
United States·private 
